Docetaxel plus epidoxorubicin as neoadju
โ
Andrea de Matteis; Francesco Nuzzo; Giuseppe D'Aiuto; Vincenzo Labonia; Gabriell
๐
Article
๐
2002
๐
John Wiley and Sons
๐
English
โ 76 KB
๐ 1 views
## Abstract ## BACKGROUND The objective of this study was to test the activity and toxicity of epirubicin plus docetaxel as primary chemotherapy for women with large, operable (T2; > 3 cm) or locally advanced (Stage III) breast carcinoma, including patients with inflammatory breast carcinoma. ##